Síndrome antifosfolípido (SAF): diferencias clínicas e inmunoserológicas entre SAF primario y secundario en una cohorte colombiana

Díaz-Coronado, Juan Camilo; Herrera-Uribe, Sebastián; Hernández-Parra, Deicy; Betancur-Vásquez, Laura; Lacouture-Fierro, Jorge; González-Hurtado, Daniel; González-Arango, Juanita; Uribe-Arango, Laura; Saavedra-Chacón, María Fernanda; Monsalve-Yepes, Santiago; Guerra-Zarama, Sebastián; Serna-Giraldo, José David; López-López, Juan David; Barbosa-Arana, Julián; Soto-Osorio, María Camila; Durango, Yecenia; Pineda-Tamayo, Ricardo A.
Rev. colomb. reumatol ; 28(3): 191-196, jul.-set. 2021. tab
Artículo en Español | LILACS | ID: biblio-1357270

Documentos relacionados

  1. Importancia de los títulos de anticuerpos antifosfolípidos no criterio entre pacientes con síndrome antifosfolípido primario y pacientes con lupus eritematoso sistémico
  2. Differences in Antiphospholipid Antibody Profile between Patients with Obstetric and Thrombotic Antiphospholipid Syndrome.
  3. Arterial Thrombosis in Patients with Antiphospholipid Syndrome: A Review and Meta-Analysis.
  4. Whole blood transcriptome identifies interferon-regulated genes as key drivers in thrombotic primary antiphospholipid syndrome.
  5. Efficacy and safety of direct oral anticoagulants versus vitamin K antagonists for left ventricular thrombus: an updated systematic review and meta-analysis.
  6. Factor XI in Carriers of Antiphospholipid Antibodies: Elevated Levels Associated with Symptomatic Thrombotic Cases, While Low Levels Linked to Asymptomatic Cases.
  7. Epidemiology of antiphospholipid syndrome: macro- and microvascular manifestations.
  8. [Predictive value of four items of new thrombus markers combined with conventional coagulation tests for thrombosis in antiphospholipid syndrome].
  9. Phenotypes in antiphospholipid syndrome: A hierarchical cluster analysis based on two independent databases.
  10. Thrombotic risk assessment in antiphospholipid syndrome: do noncriteria antibodies contribute?